These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398 [TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Graham GD Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319 [TBL] [Abstract][Full Text] [Related]
11. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774 [TBL] [Abstract][Full Text] [Related]
12. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
13. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals. Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527 [TBL] [Abstract][Full Text] [Related]
14. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Tanne D; Gorman MJ; Bates VE; Kasner SE; Scott P; Verro P; Binder JR; Dayno JM; Schultz LR; Levine SR Stroke; 2000 Feb; 31(2):370-5. PubMed ID: 10657408 [TBL] [Abstract][Full Text] [Related]
15. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341 [TBL] [Abstract][Full Text] [Related]
16. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Edwards NJ; Kamel H; Josephson SA Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701 [TBL] [Abstract][Full Text] [Related]
17. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe? Martin-Schild S; Morales MM; Khaja AM; Barreto AD; Hallevi H; Abraham A; Sline MR; Jones E; Grotta JC; Savitz SI J Emerg Med; 2011 Aug; 41(2):135-41. PubMed ID: 19272734 [TBL] [Abstract][Full Text] [Related]
18. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011. Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311 [TBL] [Abstract][Full Text] [Related]
19. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center. Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004 [TBL] [Abstract][Full Text] [Related]
20. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]